ImStem, UConn Obtain US Patent for Mesenchymal Stem Cell Technology to Treat MS, Other Diseases – Multiple Sclerosis News Today
Multiple Sclerosis News Today |
ImStem, UConn Obtain US Patent for Mesenchymal Stem Cell Technology to Treat MS, Other Diseases
Multiple Sclerosis News Today The U.S. Patent and Trademark Office has issued a patent for human embryonic stem cells derived mesenchymal stem cells, called hES-T-MSC or T-MSC, and for their method of production. This newly patented technology was developed by ImStem … |
